Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg first-in-man study
DOI 10.1161/CIRCULATIONAHA.106.639450, PII 0000301720061010000012
Grube E, Laborde JC, Gerckens U, et al. Percutaneous implantation of the self expanding valve prosthesis in high-risk patients with aortic valve disease: The Siegburg first-in-man study. Circulation 2006;114:1616-1624. (Pubitemid 44547432)
(2006)Circulation, vol.114, Issue.15, pp. 1616-1624
Percutaneous Aortic Valve Replacement for Severe Aortic Stenosis in High-Risk Patients Using the Second- and Current Third-Generation Self-Expanding CoreValve Prosthesis. Device Success and 30-Day Clinical Outcome
DOI 10.1016/j.jacc.2007.04.047, PII S0735109707015604
Grube E, Schuler G, Buellesfeld L, et al. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding prosthesis: Device success and 30-day clinical outcome. J Am Coll Cardiol 2007;50:69-76. (Pubitemid 46970878)
Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) revalving system: Results from the multicentre expanded evaluation registry 1-year following CE mark approval
Piazza N, Grube E, Gerckens U, et al. Procedural and 30-day outcomes following transcatheter aortic valve implantation using the third generation (18 Fr) revalving system: Results from the multicentre, expanded evaluation registry 1-year following CE mark approval: EuroIntervention 2008;4:242-249.
The valve-in-valve technique: Transcatheter treatment of aortic bioprothesis malposition
Ussia GP, Mule M, Tamburino C. The valve-in-valve technique: Transcatheter treatment of aortic bioprothesis malposition. Catheter Cardiovasc Interv 2009;73:713-716.